title: Diabetes insipidus in a pediatric patient with systemic lupus erythematosus. A case report.
abstract: In systemic lupus erythematosus (SLE), the central nervous system (CNS) produces numerous and varying clinical disorders. A 14-year-old girl with the features of cerebral involvement in SLE is presented. The development of diabetes insipidus (DI), which responded to desmopressin, was an interesting finding in this case. Therapy consisting of high-dose methylprednisolone combined with cyclophosphamide was effective in improving the symptoms as well as the DI.
authors.affiliation: Department of Pediatrics, Osmangazi University Faculty of Medicine, Eskişehir.
authors.forename: N
authors.initials: N
authors.lastname: Tekin
authors.forename: N
authors.initials: N
authors.lastname: Kural
authors.forename: A K
authors.initials: AK
authors.lastname: Koçak
authors.forename: S
authors.initials: S
authors.lastname: Köse
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008775:Methylprednisolone / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D003894:Deamino Arginine Vasopressin; D008775:Methylprednisolone